ReviewF1000Research2016
Recent advances in understanding and treating ARDS.
Review in F1000Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Identification of HIF1A as a therapeutic target during SARS-CoV-2-associated lung injury.JCI insight · 2025Trial
- Hypoxia Inducible Factor-2 Alpha and Prolinhydroxylase 2 Polymorphisms in Patients with Acute Respiratory Distress Syndrome (ARDS).International journal of molecular sciences · 2017Trial
- Driving pressure vs. oxygenation-based PEEP titration strategies in ARDS patients: a physiological study.Critical care (London, England) · 2025Observational
- A Sequent of Gram-Negative Co-Infectome-Induced Acute Respiratory Distress Syndrome Are Potentially Subtle Aggravators Associated to the SARS-CoV-2 Evolution of Virulence.Diagnostics (Basel, Switzerland) · 2024Article
- Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential.Inflammation · 2022Review
- Dynamic alterations in the lung microbiota in a rat model of lipopolysaccharide-induced acute lung injury.Scientific reports · 2022Article
- Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat.Stem cells international · 2022Article
- Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS.Cell biochemistry and biophysics · 2021Review
- Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.Dermatologic therapy · 2020Review
- Unfolded Protein Response supports endothelial barrier function.Biochimie · 2019Review
- Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS).Annals of translational medicine · 2019Review
- Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options.Clinical and translational medicine · 2019Review
- Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018Article
- Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.Molecular aspects of medicine · 2017Review
- Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children.Pediatric clinics of North America · 2017Review
- Acute respiratory distress syndrome.European respiratory review : an official journal of the European Respiratory Society · 2017Review
- Recent insight into potential acute respiratory distress syndrome.Saudi medical journal · 2017Review
- Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.Scientific reports · 2017Article
- HECTD2 one step closer to understand susceptibility for acute respiratory disease syndrome?Annals of translational medicine · 2016Article
- Imaging Pulmonary Inflammation.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Acute respiratory distress syndrome represents a complex syndrome with considerable morbidity and mortality, for which there exist no targeted treatment strategies. However, recent advances in clinical care have improved outcomes, and we will review a number of these approaches here, as well as explore the mechanisms underlying the benefit of intervention that might point us in the direction toward future treatment and preventive strategies for this devastating syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.